Botulinum Neurotoxin for Children With CP: a Delicate Balance Between Clinical Benefits and Muscular Harm
Recruiting
Observational Study
Spastic Cerebral Palsy (sCP)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 2 – 16
- Sex
- Any
- Study type
- Observational
- Participants needed
- 51 (estimated)
- Sponsor
- Universitaire Ziekenhuizen KU Leuven · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A cross-sectional design study will be carried out to explore the morphological muscle properties and alterations in muscle composition on a macroscopic level in children with spastic cerebral palsy (CP). Muscle composition will be assessed using quantitative Magnetic Resonance Imaging (qMRI) and shear wave elastography (SWE), while macroscopic muscle size properties will be evaluated through 'Thr…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
\- Children with spastic cerebral palsy
Inclusion criteria:
* Children (boys/girls) with congenital brain lesion, confirmed with neuro-imaging such as MRI
* At high-risk for CP or diagnosed spastic type of CP
* (Suspected) Gross Motor Function Classification Scale (GMFCS) Level I-III
* Uni or bila…
Contacts